125961-82-2

Basic information

• Product Name: Tipelukast
• Synonyms: tipelukast;4-[6-acetyl-3-[3-[(4-acetyl-3-hydroxy-2-propylphenyl)sulfanyl]propoxy]-2-propylphenoxy]butanoic acid;KCA 757;MN 001 (pharMaceutical);MN-001 (Tipelukast)
• CAS NO: 125961-82-2
• Molecular Formula: C29H38O7S
• Molecular Weight: 530.67282
• Mol File: 125961-82-2.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 735.3±60.0 °C(Predicted)
• Appearance: /
• Density: 1.22
• Storage Temp.: Hygroscopic, Refrigerator, under inert atmosphere
• Solubility: Chloroform (Slightly), Ethyl Acetate (Slightly)
• PKA: 4.59±0.10(Predicted)
• CAS DataBase Reference: Tipelukast(CAS DataBase Reference)
• NIST Chemistry Reference: Tipelukast(125961-82-2)
• EPA Substance Registry System: Tipelukast(125961-82-2)

Safety Data

• Hazardous Substances Data: 125961-82-2(Hazardous Substances Data)

Usage

Description

Tipelukast is a novel oral anti-inflammatory agent that has been found to possess significant therapeutic potential in various medical applications. It is characterized by its ability to suppress bladder hyperactivity and exhibits anti-inflammatory properties, making it a promising candidate for pharmaceutical development.

Uses

Used in Pharmaceutical Industry:
Tipelukast is used as an anti-inflammatory agent for suppressing bladder hyperactivity in a rat model. Its anti-inflammatory properties make it a potential candidate for the treatment of various inflammatory conditions and disorders.
Used in Urology:
In the field of urology, Tipelukast is used as a therapeutic agent for managing bladder hyperactivity. Its ability to suppress this condition can lead to improved quality of life for patients suffering from urinary issues and may also contribute to the development of new treatment strategies for related urological conditions.